Your browser doesn't support javascript.
loading
Boceprevir Plus Peginterferon Alfa-2a/Ribavirin in Treatment-Naïve Hepatitis C Virus Genotype 1 Patients: International Phase IIIb/IV TriCo Trial.
Ferenci, Peter; Caruntu, Florin A; Lengyel, Gabriella; Messinger, Diethelm; Bakalos, Georgios; Flisiak, Robert.
Affiliation
  • Ferenci P; Department of Internal Medicine III, Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria. peter.ferenci@meduniwien.ac.at.
  • Caruntu FA; National Institute for Infectious Diseases 'Matei Bals', Bucharest, Romania.
  • Lengyel G; 2nd Department of Medicine, Semmelweis University, Budapest, Hungary.
  • Messinger D; PROMETRIS GmbH, Mannheim, Germany.
  • Bakalos G; F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Flisiak R; Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland.
Infect Dis Ther ; 5(2): 113-24, 2016 Jun.
Article in En | MEDLINE | ID: mdl-27228998
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Infect Dis Ther Year: 2016 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Infect Dis Ther Year: 2016 Document type: Article Affiliation country: Country of publication: